153 related articles for article (PubMed ID: 31024434)
1. Anti-IL-6 Receptor Antibody Inhibits Spontaneous Pain at the Pre-onset of Experimental Autoimmune Encephalomyelitis in Mice.
Serizawa K; Tomizawa-Shinohara H; Yasuno H; Yogo K; Matsumoto Y
Front Neurol; 2019; 10():341. PubMed ID: 31024434
[TBL] [Abstract][Full Text] [Related]
2. Anti-IL-6 receptor antibody improves pain symptoms in mice with experimental autoimmune encephalomyelitis.
Serizawa K; Tomizawa-Shinohara H; Magi M; Yogo K; Matsumoto Y
J Neuroimmunol; 2018 Jun; 319():71-79. PubMed ID: 29685293
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods.
Khan N; Woodruff TM; Smith MT
Pharmacol Biochem Behav; 2014 Nov; 126():13-27. PubMed ID: 25223977
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6: evolving role in the management of neuropathic pain in neuroimmunological disorders.
Serizawa K; Tomizawa-Shinohara H; Miyake S; Yogo K; Matsumoto Y
Inflamm Regen; 2021 Nov; 41(1):34. PubMed ID: 34724990
[TBL] [Abstract][Full Text] [Related]
5. CaMKIIα Mediates the Effect of IL-17 To Promote Ongoing Spontaneous and Evoked Pain in Multiple Sclerosis.
Hu X; Huang F; Wang ZJ
J Neurosci; 2018 Jan; 38(1):232-244. PubMed ID: 29146590
[TBL] [Abstract][Full Text] [Related]
6. Pathological pain processing in mouse models of multiple sclerosis and spinal cord injury: contribution of plasma membrane calcium ATPase 2 (PMCA2).
Mirabelli E; Ni L; Li L; Acioglu C; Heary RF; Elkabes S
J Neuroinflammation; 2019 Nov; 16(1):207. PubMed ID: 31703709
[TBL] [Abstract][Full Text] [Related]
7. Experimental autoimmune encephalomyelitis (EAE) induced by antigen pulsed dendritic cells in the C57BL/6 mouse: influence of injection route.
Aghdami N; Gharibdoost F; Moazzeni SM
Exp Anim; 2008 Jan; 57(1):45-55. PubMed ID: 18256518
[TBL] [Abstract][Full Text] [Related]
8. Regulatory T Cells and Their Derived Cytokine, Interleukin-35, Reduce Pain in Experimental Autoimmune Encephalomyelitis.
Duffy SS; Keating BA; Perera CJ; Lees JG; Tonkin RS; Makker PGS; Carrive P; Butovsky O; Moalem-Taylor G
J Neurosci; 2019 Mar; 39(12):2326-2346. PubMed ID: 30651334
[TBL] [Abstract][Full Text] [Related]
9. Active Induction of Experimental Autoimmune Encephalomyelitis (EAE) with MOG
Giralt M; Molinero A; Hidalgo J
Methods Mol Biol; 2018; 1791():227-232. PubMed ID: 30006713
[TBL] [Abstract][Full Text] [Related]
10. Experimental Autoimmune Encephalomyelitis (EAE) Model of Cynomolgus Macaques Induced by Recombinant Human MOG1-125 (rhMOG1-125) Protein and MOG34-56 Peptide.
Peng Z; Zhang L; Wang H; He X; Peng X; Zhang Q; Liu H; Rao J; Wang H; Wu J; Sun Y
Protein Pept Lett; 2018 Feb; 24(12):1166-1178. PubMed ID: 29141529
[TBL] [Abstract][Full Text] [Related]
11. Changes in nociceptive sensitivity and object recognition in experimental autoimmune encephalomyelitis (EAE).
Olechowski CJ; Tenorio G; Sauve Y; Kerr BJ
Exp Neurol; 2013 Mar; 241():113-21. PubMed ID: 23291347
[TBL] [Abstract][Full Text] [Related]
12. IL-33 blockade suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Li M; Li Y; Liu X; Gao X; Wang Y
J Neuroimmunol; 2012 Jun; 247(1-2):25-31. PubMed ID: 22516472
[TBL] [Abstract][Full Text] [Related]
13. Neutralization of Interleukin-9 Decreasing Mast Cells Infiltration in Experimental Autoimmune Encephalomyelitis.
Yin JJ; Hu XQ; Mao ZF; Bao J; Qiu W; Lu ZQ; Wu HT; Zhong XN
Chin Med J (Engl); 2017 Apr; 130(8):964-971. PubMed ID: 28397727
[TBL] [Abstract][Full Text] [Related]
14. The Anti-Inflammatory Effects of Oral-Formulated Tacrolimus in Mice with Experimental Autoimmune Encephalomyelitis.
Kim MJ; Sung JJ; Kim SH; Kim JM; Jeon GS; Mun SK; Ahn SW
J Korean Med Sci; 2017 Sep; 32(9):1502-1507. PubMed ID: 28776347
[TBL] [Abstract][Full Text] [Related]
15. The role of kinin B1 and B2 receptors in the persistent pain induced by experimental autoimmune encephalomyelitis (EAE) in mice: evidence for the involvement of astrocytes.
Dutra RC; Bento AF; Leite DF; Manjavachi MN; Marcon R; Bicca MA; Pesquero JB; Calixto JB
Neurobiol Dis; 2013 Jun; 54():82-93. PubMed ID: 23454198
[TBL] [Abstract][Full Text] [Related]
16. Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery.
Samoilova EB; Horton JL; Chen Y
Cell Immunol; 1998 Sep; 188(2):118-24. PubMed ID: 9756642
[TBL] [Abstract][Full Text] [Related]
17. Myelin oligodendrocyte glycoprotein (MOG35-55)-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice.
Yun J; Gu SM; Yun HM; Son DJ; Park MH; Lee MS; Hong JT
Oncotarget; 2015 Dec; 6(38):40452-63. PubMed ID: 26564962
[TBL] [Abstract][Full Text] [Related]
18. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE).
Olechowski CJ; Truong JJ; Kerr BJ
Pain; 2009 Jan; 141(1-2):156-64. PubMed ID: 19084337
[TBL] [Abstract][Full Text] [Related]
19. Acylated and deacylated quillaja saponin-21 adjuvants have opposite roles when utilized for immunization of C57BL/6 mice model with MOG
Heidari AR; Boroumand-Noughabi S; Nosratabadi R; Lavi Arab F; Tabasi N; Rastin M; Mahmoudi M
Mult Scler Relat Disord; 2019 Apr; 29():68-82. PubMed ID: 30685444
[TBL] [Abstract][Full Text] [Related]
20. Decreased severity of myelin oligodendrocyte glycoprotein peptide 33 - 35-induced experimental autoimmune encephalomyelitis in mice with a disrupted TCR delta chain gene.
Spahn TW; Issazadah S; Salvin AJ; Weiner HL
Eur J Immunol; 1999 Dec; 29(12):4060-71. PubMed ID: 10602017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
